New Data Describing Statistically Significant Results from the Phase 2 BRIGHT Trial in Patients with Autism Spectrum Disorder (ASD) Presented at the Virtual Joint 16th International Child Neurology Congress (ICNC) & 49th Annual Child Neurology Society (CNS) Meeting

Joey Cohen
Medication Adherence

Bud Bilanich
Success Coach

Matt Turner
Patient Affordability

Frank Burrell
Scientific Storytelling

Stacey Gandler
Brand Nourishment

Liz Kane
Impactful Strategy

Brenda Snow
Authentic Patient Voice

Pat Purcell
Meeting Engagement

Amy Giles
Increasing Engagement

Suma Ramadas, PhD
Medical Affairs

Daniel Sontupe
Market Access

Matthew Durham
Omnidynamic Marketing

Paul Theisen
Patient Acquisition

David Linetsky
Point-of-Care Marketing